Search research articles
Contact Us
Filters
Showing results (121-130 of 169) with videos related to
Page
of 17
Sort By:
Cancer Research Communications
|
November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations
Radhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
Prostate Cancer and Prostatic Diseases
|
December 23, 2022
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer
Michael T Schweizer, Roman Gulati, Todd Yezefski, et al.
Cancer Research
|
May 25, 2019
Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression
Robert M Hughes, Brian W Simons, Hamda Khan, et al.
Scientific Reports
|
April 8, 2016
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity
Qing Zhong, Jan H Rüschoff, Tiannan Guo, et al.
JCI Insight
|
May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome
Xintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
The Journal of Clinical Investigation
|
April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
Alec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
European Urology Oncology
|
February 7, 2025
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after <sup>177</sup>Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes
Ruben Raychaudhuri, Abuzar Moradi Tuchayi, Soon Khai Low, et al.
The American Journal of Pathology
|
March 27, 2018
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer
Michael C Haffner, Gunes Guner, Diana Taheri, et al.
Cancer Cell
|
November 3, 2023
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
Jessica E Hawley, Aleksandar Z Obradovic, Matthew C Dallos, et al.
JCI Insight
|
December 8, 2021
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer
Navonil De Sarkar, Sayan Dasgupta, Payel Chatterjee, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 169) with videos related to
Sort By:
Page
of 17
Cancer Research Communications
|
November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations
Radhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
Prostate Cancer and Prostatic Diseases
|
December 23, 2022
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer
Michael T Schweizer, Roman Gulati, Todd Yezefski, et al.
Cancer Research
|
May 25, 2019
Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression
Robert M Hughes, Brian W Simons, Hamda Khan, et al.
Scientific Reports
|
April 8, 2016
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity
Qing Zhong, Jan H Rüschoff, Tiannan Guo, et al.
JCI Insight
|
May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome
Xintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
The Journal of Clinical Investigation
|
April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
Alec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
European Urology Oncology
|
February 7, 2025
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after <sup>177</sup>Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes
Ruben Raychaudhuri, Abuzar Moradi Tuchayi, Soon Khai Low, et al.
The American Journal of Pathology
|
March 27, 2018
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer
Michael C Haffner, Gunes Guner, Diana Taheri, et al.
Cancer Cell
|
November 3, 2023
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
Jessica E Hawley, Aleksandar Z Obradovic, Matthew C Dallos, et al.
JCI Insight
|
December 8, 2021
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer
Navonil De Sarkar, Sayan Dasgupta, Payel Chatterjee, et al.
Page
of 17